scispace - formally typeset
W

Weiyong Liu

Researcher at Huazhong University of Science and Technology

Publications -  53
Citations -  2745

Weiyong Liu is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Inflammasome & Innate immune system. The author has an hindex of 17, co-authored 51 publications receiving 1839 citations. Previous affiliations of Weiyong Liu include Jinan University & Wuhan University.

Papers
More filters
Journal ArticleDOI

Detection of Covid-19 in Children in Early January 2020 in Wuhan, China.

TL;DR: A retrospective analysis of routine surveillance data involving children hospitalized in central Wuhan, China, for acute lower respiratory infection in early 2018 found that children with Covid-19 were more likely to be diagnosed with pneumonia than the general population.
Journal ArticleDOI

RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak.

TL;DR: Phylogenetic analysis indicates that 2019-nCoV is close to coronaviruses (CoVs) circulating in Rhinolophus (Horseshoe bats), and Evolutionary analysis based on ORF1a/1b, S, and N genes suggests2019-n coV is more likely a novel CoV independently introduced from animals to humans.
Journal ArticleDOI

Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging.

TL;DR: Cardiac involvement was found in a proportion of the recovered COVID-19 patients and attention should be paid to the possible myocardial involvement in recovered COIDs patients with cardiac symptoms.
Journal ArticleDOI

Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.

TL;DR: The IL‐2R/lymphocyte was a prominent biomarker for early identification of severe COVID‐19 and predicting the clinical progression of the disease.
Journal ArticleDOI

Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central China.

TL;DR: Clinical data showed that hyperglycemia and neurologic complications were significantly higher in EV71-infected patients, while upper respiratory tract infection and C-reactive protein were significantlyHigher in CVA16-associated patients, and EV71 and CVA 16 were co-circulated during the outbreak, which may have contributed to the genomic recombination between the pathogens.